Fundz

Fundz Deep Dive

Everything you need to win Otsuka Precision Health (OPH) and Amalgam Rx — in one platform.

Who to reach, what to say, and why now on Otsuka Precision Health (OPH) and Amalgam Rx — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on Otsuka Precision Health (OPH) and Amalgam Rx — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

Otsuka Precision Health, Inc. (OPH) and Amalgam Rx Announce Launch of Elevmi™ for Caregivers Supporting Patients with Alzheimer’s Disease

Oct 07, 2024over 1 year ago

Contract Type

partnership

WilmingtonHealth Care

Description

Otsuka Precision Health, Inc. (OPH) and Amalgam Rx, Inc. have partnered to launch Elevmi™ – an intelligent digital application that helps caregivers support loved ones with Alzheimer’s Disease. Elevmi™ aims to reduce the stress and burden experienced by caregivers by enhancing their ability to manage and coordinate care for Alzheimer’s patients.

Company Information

Company

Otsuka Precision Health (OPH) and Amalgam Rx

Location

Wilmington, Delaware, United States

About

Otsuka Precision Health, Inc. (OPH) and Amalgam Rx, Inc. have partnered to launch Elevmi™ – an intelligent digital application that helps caregivers support loved ones with Alzheimer’s Disease.

Predictive Intelligence
Strategic

ML-powered predictions for Otsuka Precision Health (OPH) and Amalgam Rx's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.